Trial Profile
A phase 1 multiple dose study of nuclomedone for neuropathic pain.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Aug 2012
Price :
$35
*
At a glance
- Drugs Nuclomedone (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 16 Aug 2012 New trial record